Petros Pharmaceuticals Inc Financial Flexibility Index
Petros Pharmaceuticals Inc financial flexibility index. Petros Pharmaceuticals Inc (PTPI) has a Financial Flexibility Index of -0.05x as of March 2025. Free cash flow of $-1.49 Million (operating CF $-1.49 Million minus capex $0.00) represents 0% of total liabilities ($27.19 Million). See PTPI FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Petros Pharmaceuticals Inc (2018–2024)
Financial flexibility index of Petros Pharmaceuticals Inc from 2018 to 2024. Historical Financial Flexibility Index trend for Petros Pharmaceuticals Inc across 7 annual periods. Check PTPI cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Petros Pharmaceuticals Inc Financial Flexibility Index by Year (2018–2024)
Petros Pharmaceuticals Inc financial flexibility index by year from 2018 to 2024. Year-by-year free cash flow to debt coverage for Petros Pharmaceuticals Inc. For the full cash flow conversion analysis, see PTPI operating cash flow.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.14x | $-2.58 Million | $-2.60 Million | $18.10 Million | ▲ +60.2% |
| 2023 | -0.36x | $-7.63 Million | $-7.63 Million | $21.32 Million | ▲ +56.1% |
| 2022 | -0.81x | $-12.80 Million | $-12.80 Million | $15.72 Million | ▼ -118.6% |
| 2021 | -0.37x | $-11.86 Million | $-11.86 Million | $31.85 Million | ▼ -27.5% |
| 2020 | -0.29x | $-15.30 Million | $-15.31 Million | $52.38 Million | ▼ -664.7% |
| 2019 | 0.05x | $2.60 Million | $2.53 Million | $50.35 Million | ▼ -64.2% |
| 2018 | 0.14x | $9.90 Million | $8.02 Million | $68.57 Million | — |